false
0001807166
0001807166
2026-05-18
2026-05-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 18, 2026
Amesite Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-39553 |
|
82-3431718 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
|
607 Shelby Street
Suite 700 PMB 214
Detroit, MI |
|
48226 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (734) 876-8141
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
AMST |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events.
On May 18, 2026, Amesite Inc.
issued a press release announcing that it has secured a new enterprise customer representing an approximately 2,700-patient census—its
largest deployment to date and a major milestone in validating its enterprise strategy. A copy of the press release is attached hereto
as Exhibit 99.1 to this Current Report and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. |
|
Description |
| 99.1 |
|
Press release dated May 18, 2026 |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
AMESITE INC. |
| |
|
|
| Date: May 19, 2026 |
By: |
/s/ Ann Marie Sastry, Ph.D. |
| |
Name: |
Ann Marie Sastry, Ph.D. |
| |
Title: |
Chief Executive Officer |
Exhibit 99.1
Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise
Customer
Enterprise Deployment Validates AI-Native Infrastructure Strategy
and Proves Scalable, Cost-Efficient Execution in Non-Acute Care
DETROIT, May 18, 2026 (GLOBE NEWSWIRE) — Amesite Inc. (Nasdaq:
AMST), developer of the AI-native NurseMagic™ documentation platform and EMR for non-acute care, today announced it has secured
a new enterprise customer representing an approximately 2,700-patient census—its largest deployment to date and a major milestone
in validating its enterprise strategy.
The customer will deploy NurseMagic™ AI documentation across
its workforce to streamline workflows, integrate their EMR, and integrate with their electronic visit verification (EVV) workflow. The
deployment is expected to significantly reduce the administrative burden that currently consumes up to 16 hours1 per caregiver
per week.
This win represents a step-function increase in scale, substantially
expanding NurseMagic™’s enterprise census footprint and demonstrating the platform’s ability to operate across complex
organizations.
Dr. Ann Marie Sastry, Founder and CEO of Amesite, said, “This
2,700-census deployment validates the strength
of our architecture. We are supporting multiple roles, layered permissions, EMR and EVV integration, and custom documentation across
thousands of patients — without
the heavy consulting, technology fees, and custom development that typically drive up pricing from legacy providers. Because NurseMagic™
is AI-first, automated, and configurable, we launch new customers quickly, without weeks or months of onboarding. This achievement reflects
the successful transition from an assistive tool to core clinical infrastructure in the $1.5T+2-7 non-acute/post-acute market.
For investors, it demonstrates that our platform scales into enterprise environments while preserving strong economics, even as we continue
to maintain fiscal discipline.”
“We executed this deployment with the same financial discipline
we have applied across the company over the last several quarters,” said Sarah Berman, Principal Finance and Accounting Officer.
“By building NurseMagic™ as an AI-first, configurable platform, we have been able to automate work that historically required
significant human support. That approach has contributed to approximately 18% reduction in operating spend over the last 6 quarters, while
supporting a growing base of paying customers. As we scale into larger enterprises, we expect our automation efficiencies to
continue to benefit our unit economics and support margin expansion over time.”
Madison Bush, Director of Corporate Operations,
said “Our sales and marketing flows are delivering approximately 4,200 web visits per day and a steadily growing volume of inbound
interest from providers who are actively seeking AI-first alternatives or improvements to legacy
systems. We are already engaged in advanced discussions with additional organizations representing several thousand more patients in aggregate
census — over 70% of which self-scheduled a demo on our website.
Our recently announced major integration has made it easier for enterprises to see how NurseMagic™ fits into their existing infrastructure.
Our digital engagement, and the strength of our pipeline gives us confidence that we can meet demand for AI-native,
cost-efficient documentation at scale.”
With customers ranging from smaller providers to enterprise organizations
with thousands of patient censuses, NurseMagic™ is now proven across the full spectrum of non-acute care operations.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim
to transform the $1.5 trillion non-acute care segments. Its flagship product, NurseMagic™, streamlines documentation for nurses
and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions to improve
care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic™
meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries,
offering seamless integration into healthcare workflows and translations to over 50 languages.
Forward-Looking Statement
This communication contains forward-looking statements (including within
the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended)
concerning the Company and its business. Forward-looking statements generally include statements that are predictive in nature and depend
upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,”
“expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions
among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current
beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could
differ materially from those contained in any forward-looking statement. Risks facing the Company and its business are set forth in the
Company’s filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking
statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
Sources
| 1. | https://www.aacn.org/blog/nursing-documentation-burden-a-critical-problem-to-solve |
| 2. | https://www.grandviewresearch.com/industry-analysis/us-skilled-nursing-facility-market |
| 3. | https://www.ibisworld.com/united-states/industry/home-care-providers/1579/ |
| 4. | https://www.grandviewresearch.com/industry-analysis/us-home-healthcare-market-report |
| 5. | https://www.grandviewresearch.com/industry-analysis/us-senior-living-market-report |
| 6. | https://www.grandviewresearch.com/industry-analysis/us-hospice-market |
| 7. | https://www.aaltci.org/news/long-term-care-insurance-news/out-of-pocket-expenditures-for-nursing-home-care-expenditures-to-grow |
